PharmaZell (Germany)

PharmaZell (Germany) is a German company headquartered in Raubling, Bavaria, operating in the pharmaceutical ingredients and specialty chemicals sector. The company is known for the production of cellulose ethers and related excipients used in pharmaceutical, food, and industrial applications. Its corporate group, PharmaZell Group, maintains an international presence with production and sales activities across Europe and other markets. The company's core business revolves around high-purity cellulose ethers, which serve as binders, thickeners, and controlled-release agents in oral solid dosage forms. These materials are also employed in food, personal care, and technical applications. PharmaZell positions itself as a contract development and manufacturing organization (CDMO) and supplier to the pharmaceutical industry, offering both standard and customized excipient solutions. PharmaZell's Raubling site serves as a central manufacturing and administrative hub. The group has expanded through acquisitions and partnerships, building a portfolio that includes pharmaceutical actives and intermediates alongside its excipient range. Its customers include generic and branded pharmaceutical manufacturers, as well as food and nutrition companies. As a German mid-sized specialty manufacturer, PharmaZell competes in the global excipient market, where regulatory compliance, quality assurance, and supply-chain reliability are critical. The company emphasizes GMP-compliant production and has invested in capacity expansions to meet demand for cellulose-based excipients. Ownership and financial details are not fully public in the available evidence. The company operates under the PharmaZell Group brand and continues to serve as a notable Bavarian pharmaceutical supplier.

PharmaZell (Germany) is a company based in Raubling, Germany, as recorded in public knowledge bases. The company operates within the pharmaceutical and specialty chemicals industry, with a focus on cellulose ethers and pharmaceutical excipients. Its Raubling location serves as the primary base for its German operations. The company is part of the broader PharmaZell Group, which has developed a portfolio of pharmaceutical ingredients and excipients. Over time, the group has expanded its manufacturing capabilities and market reach, serving pharmaceutical, food, and industrial customers. The Raubling site is central to its production and administrative functions. While specific founding dates and ownership details are not available in the provided evidence, PharmaZell has established itself as a supplier in the European excipient market. The company's emphasis on GMP-compliant production and quality assurance reflects the regulatory demands of the pharmaceutical industry. PharmaZell's history is tied to the growth of the specialty excipient sector, where cellulose ethers play a critical role in drug formulation. The company has invested in capacity and technology to meet evolving customer needs, including controlled-release and high-purity applications. As of the available information, PharmaZell continues to operate from Raubling, Germany, and maintains an international presence through its group structure.

Specialty pharmaceutical excipient and CDMO supplier focused on cellulose ethers and high-purity ingredients.

• Cellulose ethers

  High-purity cellulose-derived excipients used as binders, thickeners, and controlled-release agents in pharmaceutical and food applications.

• Pharmaceutical excipients

  Functional ingredients for oral solid dosage forms, including binders, disintegrants, and release modifiers.

1. 1PharmaZell (Germany) - Wikidatawikidata.org
2. 2PharmaZell Group official websitepharmazell-group.com